Penserra Capital Management’s Ginkgo Bioworks DNA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1K	Buy	252 +6	+2%	+$50	﹤0.01%	1039
2025 Q4	$2K	Sell	246 -12,688	-98%	-$137K	﹤0.01%	970
2025 Q3	$188K	Buy	12,934 +148	+1%	+$1.77K	﹤0.01%	712
2025 Q2	$143K	Buy	12,786 +9,271	+264%	+$71.8K	﹤0.01%	685
2025 Q1	$20K	Buy	3,515 +164	+5%	+$1.67K	﹤0.01%	873
2024 Q4	$32K	Buy	3,351 +1,928	+135%	+$16.5K	﹤0.01%	983
2024 Q3	$11K	Buy	1,423 +16	+1%	+$160	﹤0.01%	888
2024 Q2	$19K	Buy	1,407 +266	+23%	+$7.94K	﹤0.01%	912
2024 Q1	$52K	Sell	1,141 -866	-43%	-$44.8K	﹤0.01%	877
2023 Q4	$134K	Buy	2,007 +200	+11%	+$12.2K	﹤0.01%	854
2023 Q3	$130K	Sell	1,807 -4,529	-71%	-$362K	﹤0.01%	841
2023 Q2	$470K	Buy	6,336 +4,147	+189%	+$245K	0.01%	540
2023 Q1	$116K	Sell	2,189 -133	-6%	-$8.43K	﹤0.01%	759
2022 Q4	$156K	Buy	2,322 +1,757	+311%	+$162K	﹤0.01%	734
2022 Q3	$69K	Sell	565 -1,029	-65%	-$123K	﹤0.01%	778
2022 Q2	$150K	Sell	1,594 -784	-33%	-$95.6K	﹤0.01%	710
2022 Q1	$382K	Buy	2,378 +383	+19%	+$74.5K	0.01%	565
2021 Q4	$661K	Buy	1,995 +798	+67%	+$379K	0.01%	468
2021 Q3	$555K	Buy	+1,197	New	+$583K	0.01%	473